What is the intrinsic value of Arbutus?

As of 2026-10-02, the Intrinsic Value of Arbutus Biopharma Corp (ABUS) is 6.59 USD. This Arbutus valuation is based on the model Peter Lynch Fair Value. With the current market price of 4.56 USD, the upside of Arbutus Biopharma Corp is 44.61%.

Is Arbutus undervalued or overvalued?

Based on its market price of 4.56 USD and our intrinsic valuation, Arbutus Biopharma Corp (ABUS) is undervalued by 44.61%.

	Range	Selected	Upside
a
DCF (Growth 5y)	(40.95) - (4.27)	(7.73)	-269.6%
DCF (Growth 10y)	(16.20) - (163.64)	(30.13)	-760.7%
DCF (EBITDA 5y)	(4.46) - (5.21)	(1,234.50)	-123450.0%
DCF (EBITDA 10y)	(16.99) - (22.48)	(1,234.50)	-123450.0%
Fair Value	6.59 - 6.59	6.59	44.61%
P/E	11.96 - 20.58	16.86	269.8%
EV/EBITDA	12.51 - 16.62	14.02	207.4%
EPV	(2.38) - (3.69)	(3.04)	-166.6%
DDM - Stable	10.26 - 125.46	67.86	1388.2%
DDM - Multi	(2.91) - (28.44)	(5.34)	-217.1%